Alba Ariela Brandes

机构：Istituto delle Scienze Neurologiche di Bologna, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0002-2503-9089

发表论文 647 篇 · 总被引 64952 次 · h-index 86

代表论文

• Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma (2024 · Acta Neuropathologica · 被引 19)
• Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 15)
• Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study (2024 · Neuro-Oncology Practice · 被引 6)
• Final clinical and molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion: NCT00626990. (2025 · Journal of Clinical Oncology · 被引 5)
• CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY (2024 · Neuro-Oncology · 被引 4)
• Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis (2026 · The Oncologist · 被引 1)